Logo 2021 MediumAsiaWorld-Expo
Hong Kong
10-13/03/2021
10-13/03/2020
Asset 2brandhk en scaled 2
 
 
 
 
X

BIOHK2021 Update 香港国际生物科技展資訊更新

BIOHK is an international convention organized by Hong Kong Biotechnology Organization to introduce novel state-of-the-art biotech innovations from around the globe and provide an extensive platform to allow pioneers of the biotech industry to convene, with the purpose of promoting Hong Kong as an international innovation hub for biotech.

However, due to the COVID-19 epidemic, BIOHK2021 had to be postponed several times and now has been decided to be postponed to 10-13 March 2021. But we are always well-prepared and ready to be the first international biotech convention after pandemic. In view of the continuing uncertainties amidst the COVID-19 epidemic, the safety of participants is definitely our prioritized concern. For any subsequent changes, we will promptly notify all stakeholders and exhibitors for getting better prepared and arranged.

It’s true that COVID-19 brings us plenty of negative impacts, on another hand, it arouses awareness in biotech and speeds up the biotech development. BIOHK2021 must be the first International Biotech Convention when COVID-19 is over. So please reserve your time to join this significant biotech event in Hong Kong.

BIOHK2021 team hereby expresses our gratitude for all those supporting to BIOHK2021. We will continue to try our best in organizing BIOHK2021, which brings biotech industry an international biotech event, with the purpose of promoting the biotech development.

Please visit this website or email to info@biohk.org.hk for any enquiries.

香港国际生物科技展是由香港生物科技协会所举办的国际会议,引入全球最创新的生物技术,及提供一个让生物科技行业聚集一堂的平台,旨在促进香港成为国际生物科技创新中心。

可是,受到新型冠状病毒疫情影响,香港国际生物科技展已推迟数次,而香港国际生物科技展现已决定延至2021年3月10日至13日举办。但是我们时刻做好充分准备成为疫情之后的首个国际生物科技大会。由于疫情存在变量,参加者安全必然是我们首要的考虑。如果科技展有任何变动,我们亦会适时通知各持份者及参展商,确保各方有充足时间作准备及安排。

确实,COVID-19给我们带来了很多负面影响,但另一方面,它引起了人们对生物科技的关注及加快生物科技的发展。当新冠肺炎结束时,香港国际生物科技展必会是第一个举办的国际生物科技大会,所以请预留时间参加这个于香港举办的生物科技盛会。

香港国际生物科技展筹委会在此感谢各方的支持,我们会尽最大努力办好香港国际生物科技展,为生物科技界带来一个国际性的生物科技活动,以促进生物科技发展。

如有查询,请浏览本网站或电邮至 info@biohk.org.hk

Convention Theme 

  • Biotech Kaleidoscope: to create a global platform in which there are infinite possibilities and zero limitations on what you can accomplish

What is BIOHK2021?

An international convention organized by HKBIO to introduce novel state-of-the-art biotech innovations from around the globe, with the purpose of providing an extensive platform to allow pioneers of the biotech industry to convene. From infectious diseases like COVID-19, to the latest cancer treatments and diagnostics to big data analytics, BIOHK2021 is an unparalleled event covering the most relevant and timely topics in biotechnology
 
BIOHK2021 comprises of three parts:

Exhibition - SHOWCASE and CONNECT
  • Showcase your product to the world whilst simultaneously learning about other leading innovations
Conference and Pitch Sessions - SHARE AND INSPIRE
  • Take part in invaluable discussions about the latest topics and industry trends in biotech
One2One Partnering - PROMOTE AND ESTABLISH
  • Promote your company and connect with prospective partners in the biotech market, succeed in forming new collaborations and building your international network
On the last day of the convention, the convention will be open to the public and visitors will be able to participate in public talks. Use this opportunity to promote your company brand and products!


Register now and see you at BIOHK2021!

 

Register now

 


Organizers

HKBIO Logo Hong Kong Biotechnology Organization (HKBIO) established in 2010 by reputable industry and esteemed academic representatives, HKBIO is a non-profit organization which continuously strives to promote Hong Kong as the biotech hub of Asia. HKBIO has organized and sponsored several successful events in the past that highlighted the substantial potential of Hong Kong’s Biotechnology sector.
BH logo The BayHelix Group is a non-profit professional organization of business leaders with a mission to shape the growth of the life sciences and healthcare industry. Founded in 2001 in the San Francisco Bay Area, BayHelix has grown to over 800 members globally with a strong presence in China and the US. BayHelix aspires to foster and create business opportunities, supply and nurture leaders for the community, and network and share information and experience among its members.
Ausvic Capital Ausvic Capital (“Ausvic”) is a global biotech, Artificial Intelligence (AI) and cloud computing-focused investment group founded by Mr. Chen Ping and a group of leading investors in 2018. Mr. Chen and his team began their track record of successful biotech and AI investing globally and the founding partners all have a deep root in entrepreneurship in China and globally. Today, Ausvic leverages its extensive network around the world and focused on some of the world’s most novel life science and AI-related companies and technologies in the United States, Europe, and China.

 

Co-organizers

gba Guangdong-Hong Kong-Macao Greater Bay Area initiative, corralling the two Special Administrative Regions (SARs) of Hong Kong and Macao with Guangdong, one of the richest province of China’s 34 provinces. Greater Bay Area seems to possess the same core components as “the original” Bay Area: Hightech IT sectors, electronics hardware capabilities, riotous VC activity, vibrant academic and basic science research, favourable government policy, and a huge market.
NFCR logo web blue 61027 e1489677271529 The National Foundation for Cancer Research (NFCR) is a non-profit organization that provides scientists in the lab the funding they need to make and apply game-changing discoveries in cancer treatments, detection, prevention and, ultimately, a cure. It has distinguished itself in the cancer sector by emphasizing long-term, transformative research often overlooked by other major funding sources. With the help of more than 5.3 million individual donors over the last 46 years, NFCR has delivered more than $380 million in funding to public education and cancer research leading to several important, life-saving discoveries. 
WeChat 圖片 20190715150135 The Asian Fund for Cancer Research Limited (AFCR) is committed to fund cancer research, especially those cancers prevalent in Asian populations, and promote global collaborations for high impact to save the lives of cancer patients.
Guangdong Medical Valley Guangdong Medical Valley (GDMV), established in 2014, specializing in medical instrument and bio-pharmaceutical industry,is an all-around investment incubation platform, including the medical equity investment and medical industry supporting service. It is the one of the founders of China Medical Industry Alliance and the standing council unit of Guangdong Medical Device Management Association.